About
Mimetic Medicines develops novel, long-acting, non-opioid drug candidates for chronic pain using a proprietary short lipidated peptide platform targeting ion channel and scaffold protein complexes.
Explore Mimetic Medicines's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.